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Abstract   
Background 
Emerging evidence from cohort studies indicates that adiposity is associated with greater incidence 
of head and neck cancer (HNC).  However, most  studies have used self-reported anthropometry 
which is prone to error. 
Methods 
Among 363 094 participants in the European Prospective Investigation into Cancer and Nutrition 
study (EPIC) with measured anthropometry, there were 837 incident cases of HNC.  HNC risk was 
examined in relation to body mass index (BMI) [lean:  < 22.5 kg/m2, normal weight (reference): 22.5-
24.9 kg/m2, overweight 25-29.9 kg/m2, obese: > 30 kg/m2], waist circumference (WC), hip 
circumference (HC) and waist to hip ratio (WHR) using Cox proportional hazards models.  
Results 
Among men, a BMI < 22.5 kg/m2 was associated with higher HNC risk [hazard ratio (HR) 1.62, 95% 
confidence interval (CI) 1.23 – 2.12)]; BMI was not associated with HNC among women.  WC and 
WHR were associated with greater risk of HNC among women, (WC per 5 cm: HR 1.08, 95% CI 1.02 – 
1.15; WHR per 0.1 unit: HR 1.64, 95% CI 1.38 – 1.93).  After stratification by smoking status, the 
association for WHR was present only among smokers (p interaction 0.004).  Among men, WC and WHR 
were associated with HNC only upon additional adjustment for BMI (WC per 5 cm: HR 1.16, 95% CI 
1.07 – 1.26; WHR per 0.1 unit: HR 1.42, 95% CI 1.21 – 1.65). 
Conclusion   
Central adiposity, particularly among women, may have a stronger association with HNC risk than 
previously estimated.     
Impact  
Strategies to reduce obesity may beneficially impact HNC incidence.  
 
Running title:  Measured anthropometry and head and neck cancer in EPIC 
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Introduction 
Cancers of the oral cavity, pharynx and larynx (known collectively as head and neck cancers, 
or HNC) are the sixth most common form of cancers worldwide (1).  HNC is positively associated with 
tobacco (2), alcohol (2) and human papillomavirus (HPV), especially HPV-16 (3).  Evidence from case-
control studies suggest that adiposity was inversely associated with the risk of HNC (4-12), an 
observation that was in contrast to the positive association with BMI for other cancer sites, such as 
breast, oesophagus (adenocarcinoma), endometrium and colon (13-16).  Initial results from two 
prospective studies indicated that BMI classification was not associated with HNC risk (17, 18), but 
the number of cases in both studies (n < 350) limited the capacity for subgroup analysis.   
Subsequently, evidence of a divergent association for measures of anthropometry and HNC was 
reported by a large pooled consortium of twenty cohort studies (19): BMI was inversely associated 
with HNC risk among current smokers, whereas it was positively associated with HNC risk among 
non-smokers.  Furthermore, greater abdominal obesity (waist circumference or waist to hip ratio) 
was associated with higher HNC risk in the consortium study, regardless of smoking status (19).  
These results represent a substantial development in the characterization of anthropometry and 
HNC.  However, the majority of studies in the pooled cohort relied on self-reported measures of 
anthropometry, which are prone to error (20-22).    Greater precision in the estimates of the 
relationship between anthropometry and HNC could be gained through analysis of those with 
measured anthropometry.   
The aim of the present analysis was to examine the association between measures of  
general adiposity (BMI), central adiposity (waist circumference, hip circumference and waist to hip 
ratio) and HNC among participants in the European Prospective Investigation into Cancer and 
Nutrition (EPIC), further evaluating associations for differences by smoking status.  Our analysis also 
incorporates information on changes in smoking status and weight after baseline, which (to the best 
of our knowledge) has not previously been included in analyses of anthropometry and HNC risk.    
Materials and Methods 
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General study description 
EPIC is a multi-centre prospective cohort study, which recruited 521 448 volunteers from 23 
centres in 10 countries (Denmark, France, Germany, Greece, Italy, Norway, the Netherlands, Spain, 
Sweden, and the United Kingdom) between 1992 and 2000. The study design and population has 
been described in detail previously (23, 24). In brief, the study included volunteers aged mostly 25 to 
70 years at the time of recruitment. Questionnaires on diet, education, occupation, previous 
illnesses, alcohol, tobacco consumption, and physical activity were completed by participants.    The 
study was approved by all relevant ethical review boards, and all participants provided consent for 
the retention of acquired data and follow-up for incidence of cancer and death.  
Study sample 
There were 491 992 eligible participants who had no history of prevalent cancer (except for 
non-melanoma skin cancer) at baseline and complete information on length of follow-up.  
Participants were excluded if they had missing measurements of height or weight, waist 
circumference (WC, centimetres) and hip circumference (HC)  (n=88,874), self-reported smoking 
status (n=11,696) or baseline alcohol intake (n=6,199), or had extreme anthropometric values 
(height greater than 244 cm or less than 122 cm (n=6); BMI less than 15 kg/m2 (n=48) or greater than 
60 kg/m2 (n=56); WC less than 40 cm (n=0) or greater than 160 cm (n=14).  In total,  363,094 
participants were included in the current analysis.   
Follow-up and assessment of HNC 
To identify incident cases of HNC and assess vital status of the participants during follow-up 
data from population-based cancer registries and mortality registries were used, with exception of 
France, Germany, Greece and Naples (Italy), where a combination of different active follow-up 
methods were applied. The last date of follow-up varied by EPIC centre, and ranged from June 2008 
to December 2013.   
We applied the same definition of HNC as used by the INHANCE consortium (2), which 
consists of five sub-sites identified by the following ICD10 [International Classification of Diseases]-
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10  codes: oral cavity (C00.3–C00.9, C02.0–C02.3, C03.0, C03.1, C03.9, C04.0, C04.1, C04.8, C04.9, 
C05.0, C06.0–C06.2, C06.8, and C06.9),  oropharynx (C01.9, C02.4, C05.1, C05.2, C09.0, C09.1, C09.8, 
C09.9, C10.0–C10.4, C10.8, and C10.9), oral cavity, pharynx unspecified or overlapping (C02.8, C02.9, 
C05.8, C05.9, C14.0, C14.2, and C14.8; 5), hypopharynx (C12.9, C13.0–C13.2, C13.8, and C13.9) and 
larynx (C32.0–C32.3 and C32.8–C32.9).  Tumour stage (I–IV) was based either on the TNM staging 
(n=169), the categories “localized/metastatic/metastatic regional/metastatic distant” provided by 
study centres (n=176),  or was missing/unknown (n=492). 
Assessment of anthropometry 
Body weight (kilograms) and height (centimetres) were measured according to standardised 
procedures without shoes during a clinic visit (25).  In the ‘Health-conscious’ group in the UK, 
measured data was not available from all participants; instead, self-reported anthropometric data 
was adjusted using prediction equations derived from a subset of participants for whom both self-
reported and measured anthropometric data were available (22). WC was measured at the 
narrowest torso circumference or at the midpoint between the lower ribs and iliac crest according to 
study centre, except in Norway and Umeå (Sweden), where WC was not measured.  HC 
(centimetres) was measured over the buttocks or at the widest point.  To account for between-
centre methodological heterogeneity, we subtracted 1.5kg from weight and 2.0cm from waist and 
hip circumference for participants who were measured while normally dressed.   We subtracted 1kg 
for weight for participants who were measured in light clothing (25).   
Data analysis 
Hazard ratios (HRs) and 95% confidence intervals (95% CI) for associations between 
anthropometric measures of adiposity and HNC were estimated using Cox proportional hazard 
models with age as the time scale (time of entry: age at recruitment, time of exit: age of diagnosis of 
HNC, loss to follow-up or death, whichever came first). The Cox models were stratified by centre, 
smoking status, and age at recruitment in 1-year categories. Inspection of Schoenfeld residuals 
indicated that the proportional hazards assumption was not violated.  BMI groups were classified as 
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follows:<22.5 kg/m2 (lean), 22.5-24.9 kg/m2 (normal weight), 25-29.9 kg/m2 (overweight), and >30 
kg/m2 (obese); this is a modification of the  standard World Health Organization BMI cut-points (26) 
in order to reflect BMI 22.5 – 24.9 kg/m2 as the lowest mortality risk group (27)  
The dose-response relationship was examined by fitting Cox proportional hazards models 
with restricted cubic splines for BMI, WC, and WHR as continuous variables, adjusted for the same 
covariates as before analysis. Knots were placed at the 5th, 25th, 75th and 95th percentiles of the 
anthropometric measurement followed by corresponding likelihood ratio tests comparing the 
goodness-of-fit of the models with and without the spline terms   (28, 29). 
Analyses of WC and WHR were conducted with and without inclusion of BMI (continuous) as 
described by Pischon et al. (30). WC and HC were examined independently and in mutually adjusted 
models to evaluate the relative contribution of the components of WHR.   Wald tests based on cross-
product terms were used to examine potential interactions between HNC and BMI (categorical, as 
described above), WC, HC and WHR across sex, smoking status and alcohol intake [non-drinkers, 
light drinkers (< 12 g/day) or moderate/heavy drinkers (>12 g/day)].   We also fitted models 
separately by HNC sub-sites (oral cavity, oropharynx, hypopharynx, and larynx), in which 
heterogeneity across sites was assessed by joint Cox proportional hazards models (31).  For all 
models, the potential confounders selected a priori were smoking (current, former, never), 
education (none/primary school, technical/professional, secondary, longer education, or missing) 
and baseline alcohol intake [non-drinkers, >0 –6 g/day, >6 –12 g/day, >12-24 g/day, >24 –60 g/day 
(men) or >24 –36 (women), >60 –96 g/day (men) or >36 g/day (women), > 96 g/day (men)].   
Sensitivity analyses were undertaken to explore adjustment for physical activity, fruit and 
vegetable intake, detailed smoking history [age at smoking initiation, lifetime number of cigarettes 
per day, current number of cigarettes per day (current smokers),  and time since quitting (former 
smokers)], adjustment for lifetime alcohol intake [never drinkers, past heavy drinkers (women: 
>30g/d women, men >60/d; during any past decade starting at age 20), and never heavy drinkers 
(women: never > 30g/d, men never >60g/d )]. In further sensitivity analyses, we excluded the first 
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three years of follow-up and restricted the analysis to stage I (localized) and stage II (metastatic) 
cancers in order to reduce the likelihood of including undiagnosed cases with disease-related weight 
loss at baseline.  The impact of changes in smoking status or weight after follow-up was explored in a 
sub-set of participants from the EPIC-PANACEA study (described in detail elsewhere (32)), from 
whom self-reported data was collected again two to 11 years after baseline (average 5 years; n = 
268,185 for the present analysis).  For complete correspondence to INHANCE definition of HNC, the 
analyses were repeated for squamous cell carcinomas only (n= 742 cases).  Lastly, the calibrated 
anthropometric data that was derived from self-reported measures from a subset of Oxford 
participants (n = 40,417, including 44 HNC cases) was excluded to evaluate any impact on 
associations detected.  
All analyses were conducted with SAS version 9.3 (SAS Institute Inc., Cary, NC).   
   
Results   
Baseline characteristics 
During a median follow-up of 15.1 years, there were 584 incident HNC cases among 126 307 
men, and 253 incident HNC cases among 236 787 women.  The majority (88.8%) of HNC cases were 
squamous cell carcinomas. Baseline characteristics are presented in Table 1.  Compared to the other 
BMI groups, lean men and women reported a higher frequency of current smoking, higher education 
levels and lower mean age, WC, HC, and WHR.   Scatterplots of the associations between BMI 
(kg/m2) and measures of central adiposity, illustrate a relatively stronger correlation between BMI 
and WC (Supplementary Figure 1a) compared to BMI and WHR (Supplementary Figure 1b). 
Preliminary analyses indicated interactions by sex between HNC risk and WC (P value 0.029) 
and WHR (P value 0.006), therefore subsequent analyses were stratified by sex, including BMI (P for 
interaction by sex 0.077).  Spline analyses indicated a non-linear association between BMI and HNC 
among men (P nonlinearity 0.0011 (Figure 1)); the corresponding P value for women was 0.20.  There 
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was no evidence of non-linearity in relation to HNC risk for WC, HC or WHR among men (P values 
0.060, 0.23, and 0.29 respectively) or women (P values 0.55, 0.73, 0.74 respectively).  
 
BMI and HNC 
A greater risk of HNC was detected among men with a BMI < 22.5 kg/m2 (HR 1.62, 95% CI 
1.23 – 2.12) compared to the reference category (BMI 22.5 – 24.9 kg/m2), but no associations were 
detected among those with relatively higher BMI classification (Table 2). Among women, there were 
no associations between BMI level and HNC risk (Table 2).  Following stratification by smoking status, 
greater risk of HNC was detected among current smokers with BMI < 22.5 kg/m2  (for both men and 
women), and a marginally significant greater risk of HNC was detected among women never smokers 
with BMI > 30 kg/m2 (HR 1.90, 95% CI 0.98 – 3.71, P value 0.058).  However, testing for significant 
interactions between HNC risk and smoking status yielded null results (P values 0.68 and 0.35 among 
men and women respectively) therefore observed variation between groups must be interpreted 
with caution.   
 
WC and HNC 
 WC was not associated with HNC risk among men in the model adjusted for education and 
alcohol intake (Table 2); however, further adjustment for BMI yielded a positive association (per 5 
cm HR 1.16, 95% CI 1.07 – 1.26).  In contrast, WC among women was associated with HNC risk 
independent of adjustment for BMI [per 5 cm HR 1.08 (95% 1.02 – 1.15)]. There was no evidence of 
an interaction between WC and smoking status in relation to HNC risk for men or women, with or 
without adjustment for BMI.    
 
WHR and HNC 
 A marginally positive association was detected by WHR and HNC risk among men (HR per 0.1 
unit 1.14, 95% CI 0.99 – 1.30, P value 0.07); a stronger association was detected after adjustment for 
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BMI (Table 2).  Among women, WHR was positively associated with HNC risk (HR per 0.1 unit 1.64, 
95% CI 1.38 – 1.93); this association was only marginally altered by further adjustment for BMI.   A 
significant interaction between WHR and HNC risk across smoking groups was detected among 
women (P value 0.004) but not men (P value 0.63).  Each 0.1 unit higher WHR was associated with a 
more than two-fold higher risk of HNC among female smokers, whereas no association was detected 
among never or former smokers.   
 
WC, HC, and HNC 
 WC and HC were both independently associated with HNC risk among men and women, with 
effects in opposing directions:  a higher WC (per  5cm, adjusted for HC)  was associated with greater 
HNC risk (men HR 1.11, 95% CI 1.03-1.19; women HR 1.29, 95% CI 1.18 – 1.41), whereas a higher HC 
(per 8 cm, adjusted for WC)  was associated with lower HNC risk (men HR 0.69, 95% CI 0.59 – 0.82; 
women HR 0.64, 95 % CI 0.53 – 0.76). There was no evidence of an interaction between WC 
(adjusted for HC) and smoking status among men or women.  In contrast, for HC (adjusted for WC), 
the interactions in relation to smoking status were significant for women (P value 0.0002) and 
suggestive among men (P value 0.07), with relatively stronger effects seen among current smokers.   
Among men, the results for HC were broadly similar whether or not WC was adjusted for in the 
analyses. Among women, however, HC without adjustment for WC was not associated with HNC risk 
overall,  with opposing effects observed for never smokers (HR 1.21, 95% CI 1.01 – 1.33) and current 
smokers (HR 0.68, 95% CI 0.55 – 0.84) (P for interaction 0.002). 
 
Subgroup and sensitivity analyses 
There was no evidence of heterogeneity across HNC sub-sites (oral, oropharyngeal, 
hypopharynx, or larynx) in relation to BMI, WC, or WHR among men or women (Table 3).  In 
contrast, there was evidence that the association between HC (adjusted for WC) and lung cancer risk 
varied by HNC site among women (P 0.033), with all HR values significantly below 1. Similarly, tests 
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for interactions between alcohol intake and BMI, WC, or WHR in relation to HNC risk yielded non-
significant values (data not shown).   Additional adjustment for details of smoking history [age at 
smoking initiation, lifetime number of cigarettes per day, current number of cigarettes per day 
(current smokers), and time since quitting (former smokers)], lifetime alcohol intake, fruit and 
vegetable intake, physical activity, exclusion of the first three years of follow-up, or restriction to 
stage I and II cancers (n= 235 cases) did not materially alter the results presented in Table 2 (data not 
shown).  Similarly, additional adjustment for weight gained between baseline and the second 
questionnaire yielded negligible changes to the results obtained without this information included in 
the models (Supplementary Table 1). Upon restricting the analysis to those who were never or 
current smokers at baseline and at the time of the second questionnaire, results for WC, HC and 
WHR in relation to HNC risk were broadly unchanged among men and women (Supplementary Table 
2); as an exception, WC among never smoking men was significantly associated with HNC risk (HR 
1.26, 95%CI 1.04 – 1.53). The corresponding analysis for BMI yielded null results for men and women 
(Supplementary Table 2); however, the reduction in the number of HNC cases per BMI subgroup is 
noteworthy.  Following the exclusion of participants from Oxford with calibrated self-reported 
anthropometric measurements, there were no material changes to the results obtained for 
measures of adiposity and HNC among men (Supplementary Table 3). Among women, excluding the 
calibrated self-reported values yielded more strongly positive associations with HNC risk for those 
with  low BMI (HR 1.58, 95%CI 1.06-2.36), among obese never smokers (HR 2.33, 95% CI 1.10 - 4.93) 
and among low BMI current smokers (HR 2.22, 95%CI 1.26 – 3.89) (Supplementary Table 
3).   Similarly, restriction of the analysis to squamous cell carcinomas did not materially change the 
nature of the results detected (data not shown). 
Discussion   
In this large, prospective cohort of over 360,000 individuals, greater levels of central 
adiposity (WC and WHR) were associated with higher risk of HNC among women and men;  among 
men, statistically significant associations for central adiposity were detected only after further 
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adjustment for BMI.  Low BMI (< 22.5 kg/m2) was associated with greater risk of HNC among men 
compared to the reference category (22.5-24.9 kg/m2); stratification by smoking status yielded 
higher risk among male and female smokers with low BMI.   However, caution is required in 
interpretation of this subgroup analysis due to not having found evidence for a statistically 
significant interaction between BMI and smoking status in relation to HNC risk.  Among women, 
there was evidence of an interaction between WHR and smoking status in relation to HNC. 
Stratification by smoking yielded a strong positive association between WHR and HNC risk among 
current smokers among women; mutual adjustment for WC and HC indicated that this is explained 
by a relatively stronger protective effect of higher HC, rather than high risk associated with greater 
WC.  The observed associations were not explained by variation in self-reported alcohol or tobacco 
exposure history.   Similarly, the results were not materially changed by excluding the first three 
years of follow-up, thus reducing the likelihood of cases presenting with disease-related weight loss 
at baseline.   There was no evidence of confounding by other lifestyle factors, including physical 
activity and fruit and vegetable intake, but the possibility of confounding by unknown or 
unmeasured factors remains.   Therefore, the observed higher HNC incidence for males with low 
BMI, and female smokers with greater WHR values, requires confirmation in other studies.    
Many of our results were consistent with those of the large cohort studies (33, 34) and 
pooled analysis of anthropometry and HNC (19) (the latter of which included data from an earlier 
follow-up of the EPIC cohort).  The strength of the associations detected for BMI and WHR in relation 
to HNC risk in the NIH-AARP study, the largest single cohort study to date on this topic, (33) were 
broadly consistent with those reported in the present study for men; it is likely that their HNC cases 
were predominantly men, given a higher incidence of HNC among men and the higher proportion of 
men (60%) in the NIH-AARP cohort (33).  As in the present study,  the risk of HNC in the Netherlands 
Cohort Study (NLCS) was significantly higher among those with relatively low BMI values (34). 
However, further comparison of the results by smoking status is limited as there was no evidence of 
non-linearity between BMI and HNC risk in NLCS and therefore BMI analysed as a continuous 
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variable among smoking subgroups.  Similar to the present results, the pooled analysis reported that 
HNC risk was positively associated with WC and WHR and inversely associated with HC (among 
smokers only) (19), but found no evidence of an interaction across smoking groups in the pooled 
analysis.  Stronger associations were detected for the measured anthropometric data used in the 
present analysis compared to the pooled analysis. However, the heterogeneity in the association 
between BMI and HNC by smoking status in the pooled analysis was not replicated in the present 
study; this may have been due to limited HNC cases in some BMI groups.  The pooled consortium 
study is the largest analysis to date, and comprised predominantly self-reported anthropometric 
data (including some EPIC centres where only self-reported data was collected). Discrepancies in 
results between the present and the pooled analysis may be due to factors other than error 
introduced by self-reported anthropometry; for example, in the consortium analysis adjustment was 
made for genetic ancestry.  However, the impact of misclassification by self-reported anthropometry 
is well-established, particularly when categories are used as the unit of analysis (22).  If central 
adiposity is positively associated with HNC risk, evidence that self-reported WC and WHR values are 
lower among those with greater BMI and larger waist size (35, 36) suggests that estimates of self-
reported central adiposity and HNC risk may be biased towards the null.   Overall, the pooled 
consortium study provided strong evidence of a positive association between adiposity and HNC, 
particularly for abdominal obesity and among never smokers, and had a substantial sample size that 
enabled thorough study of subgroups.  The results from the present analysis further support the 
findings of the pooled analysis and highlight the urgency to implement effective policies to reduce 
obesity.   
A novel observation that emerged from the present analysis was relative strength of 
association between central adiposity and HNC risk among women compared to men, and the 
apparent inverse association between HC (adjusted for WC) and HNC risk, particularly among 
smokers.    Previously within the EPIC cohort, WC-adjusted HC has been positively associated with 
the risk of oesophageal cancer, although no interactions by smoking status were detected (16).     
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It has been proposed that greater subcutaneous fat storage on the hips may be associated with 
reduced cancer risk by serving as a “metabolic sink” to prevent lipotoxic effects (37, 38), but this 
mechanism has not been established.    Similarly, as there are no established biological pathways for 
an association between adiposity and HNC risk, it is difficult to speculate why such effects might 
differ by sex.  Proposed mechanisms for adiposity-cancer associations include insulin and insulin-like 
growth factors, sex steroids, adipokines and systematic inflammation (39)   These proposed 
pathways are supported by evidence from cohort studies and randomized controlled trials that 
intentional weight loss is associated with lower levels of oestrogen, oestradiol, inflammatory 
markers and lower incidence of cancers at a range of sites (40).   Mechanistic evidence regarding 
adiposity and HNC is limited, but includes a small study of laryngeal cancer patients in which higher 
levels of leptin expression were detected in tumour tissue compared with healthy tissue, and a 
positive association between leptin expression and cancer recurrence was noted (41).  Excess 
adipose tissue is typically stored centrally for men but gluteofemorally for women (42), therefore the 
accumulation of central adiposity among women may be indicative of metabolic imbalances (i.e. 
excess androgens, as noted in polycystic ovarian syndrome (43)) that would not be observed among 
men. Given the novelty of the present findings, further sex-stratified analysis in other populations is 
required to confirm that these differences are pervasive in the context of measured anthropometry.  
BMI-adjusted central adiposity was associated with HNC in the present analysis, however, 
we would advise caution in the interpretation of mutually adjusted anthropometric values. WC and 
WHR are both highly correlated with BMI, and so the interpretation of relative risks for an increment 
in these variables for a given BMI is not straightforward. That is, for a given fixed BMI the variability 
in WC and WHR is limited. The adjustment for multiple aspects of anthropometry in relation to HNC 
is particularly complex within the context of smoking status.  BMI is typically lower among current 
smokers than among former or never smokers (44-47), possibly as a result of decreased appetite 
(48), higher resting metabolic rate (49-51), or morbid conditions that make them lean.  Smokers, 
despite lower weight, also have a higher WC, lower HC, and higher WHR values than non-smokers on 
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average (52).  These differences are more pronounced among smokers with relatively greater 
smoking intensity and former smokers with comparatively shorter duration since quitting, and are 
not attenuated by adjustment for physical activity, energy intake, alcohol intake, and education (46).  
Possible explanations for these differences are proposed estrogenic effects of smoking (53), or 
uncontrolled confounding for self-reported factors that are prone to error (e.g. lower HC among 
current smokers could reflect lower physical activity and consequent muscle wasting in the gluteal 
region).   
 Strengths of the present study include the prospective design, availability of measured 
anthropometry, wide range of exposure values, and large sample size that enabled stratification by 
smoking status.   The availability of detailed data on past smoking habits and alcohol intake 
facilitated thorough evaluation for potential confounding through these exposures.   However, the 
study has also some limitations.  First, there were a relatively small number of cases in some BMI 
groups in the analyses run separately by smoking status and by HNC site, particularly among never 
smokers and for cancers of the hypopharynx; the power for related interaction tests may have been 
limited, particularly among women.   Further, there is uncertainty as to what the most appropriate 
reference category and classification system ought to be applied to BMI: the present analysis 
combined all individuals with BMI < 22.5 kg/m2, using 22.5-24.9 kg/m2 as the reference group.  The 
WHO classification system identifies those with BMI < 18.5 kg/m2 as underweight, therefore we may 
have reduced our ability to detect associations between underweight and HNC by setting our lowest 
category as 15.0 – 22.5 kg/m2.  However, there was a limited number of participants with measured 
BMI < 18.5 kg/m2 (n=4604, including six male and four female HNC cases) therefore the impact of 
combining underweight and low-normal weight individuals in the present study is unlikely to have 
been substantial.  The spline analysis indicated that the BMI values with the lowest risk of HNC may 
differ for men and women, as does the magnitude of risk associated with relatively lower BMI 
values; further research is needed to confirm and characterize these differences by sex.  Lastly, the 
use of measured anthropometry in the present study yielded larger effect sizes than seen in previous 
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research where self-report has been used, and we propose that this discrepancy may be due to the 
error that is known to exist for self-report.  However, this cannot be confirmed in the absence of 
both measured and self-reported data on the same subjects.  We could not undertake such a 
comparison as the majority of EPIC participants had measured anthropometry only, with only 12% of 
the present sample having both measured and self-reported values.  
Summary 
The present analysis yielded evidence of a positive association between central adiposity 
and HNC, particularly among women, with larger effect sizes detected than in previous studies using 
self-reported anthropometry.   If a causal association exists between adiposity and HNC, the 
increases in global obesity prevalence observed over time (54) may also result in higher incidence of 
HNC.  In addition to continued emphasis on smoking cessation, efforts to address the prevalence of 
obesity may therefore contribute to lower incidence of HNC.  
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Table 1:  Baseline demographic, anthropometric and lifestyle characteristics  by sex and BMI group in the EPIC study   
 Men a Women a 
 BMI (kg/m2) BMI (kg/m2) 
 <22.5 (n=13 700) 
22.5-24.9 
(n=29 353) 
25-29.9 
(n=62 510) 
≥30 
(n=20 744) 
<22.5 
(n=65 653) 
22.5-24.9 
(n=59 548) 
25-29.9 
(n=74 972) 
≥30 
(n=36 614) 
Age at recruitment(years) 50.1 (12.2) 52.5 (10.1) 53.7 (9.0) 54.1 (8.6) 47.6 (11.3) 51.0 (10.3) 53.3 (9.6) 54.3 (9.2) 
Follow-up (years) 13.9 (4.5) 13.9 (4.4) 13.7 (4.4) 13.1 (4.6) 14.3 (3.9) 14.3 (3.9) 14.1 (4.0) 13.8 (4.1) 
WC (cm) 81.3 (5.7) 88.0 (5.3) 96.3 (6.2) 109.1 (8.1) 69.8 (5.3) 76.2 (5.7) 84.1 (7.0) 97.8 (9.7) 
HC (cm) 92.9 (4.5) 96.9 (4.2) 101.6 (4.7) 109.7 (6.7) 92.7 (4.8) 98.0 (4.6) 103.9 (5.3) 115.4 (8.6) 
WHR 0.88 (0.05) 0.91 (0.05) 0.95 (0.05) 1.00 (0.06) 0.75 (0.06) 0.78 (0.06) 0.81 (0.07) 0.85 (0.07) 
         
Smoking status (%)         
Never  36.2 33.4 29.4 26.3 53.8 53.4 58.0 65.8 
Former   25.6 34.6 40.8 43.5 23.1 24.9 22.8 19.4 
Current   38.2 32.1 29.8 30.2 23.1 21.7 19.2 14.8 
         
Alcohol intake, g/d  (%)         
Non drinker 7.2 6.0 6.8 8.5 10.0 12.9 19.5 30.1 
>0-6(M)/>0-3(W)   25.7 21.6 19.9 20.6 28.7 27.8 29.3 32.7 
>6-12 (M)/>3-12 (W)   17.4 17.2 16.0 14.6 33.5 32.1 28.9 23.1 
>12-24   21.4 23.2 22.3 19.5 17.0 16.7 13.6 8.6 
>24-60 (M)/> 24-36(W)   22.5 26.1 27.6 26.4 6.8 6.4 5.1 3.2 
>60-96 (M)/>36 (W)   4.6 5.0 6.1 7.8 4.0 4.1 3.5 2.4 
>96 (M)  1.3 1.0 1.4 2.6     
         
Education (%)         
Missing  3.2 2.5 2.0 1.7 4.4 4.4 4.0 3.5 
Primary school completed   22.2 26.5 37.0 49.8 15.7 26.4 42.0 58.2 
Technical/professional school   24.9 25.0 25.1 22.3 24.5 26.3 24.0 19.2 
Secondary school   14.8 13.2 10.8 8.7 22.3 19.2 14.6 9.9 
Longer education (incl. 
University degree)  
35.0 32.8 25.1 17.5 33.2 23.6 15.4 9.2 
a Data are mean (SD) unless otherwise specified.  (M) = men, (W) = women 
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Table 2:  Measures of adiposity and the risk of HNC among EPIC participants, by smoking status  
  All participants  Never  Former  Current  
Men 
n cases HR (95% CI) a n cases HR (95% CI) b n cases HR (95% CI) b n cases HR (95% CI) b P interaction 
smoking status         
BMI   
<22.5 kg/m2 93 1.62 (1.23 – 2.12) 7 1.22 (0.48 – 3.09) 13 1.41 (0.73 – 2.73) 73 1.70 (1.24 – 2.34) 0.68 
22.5-24.9 kg/m2 130 1.0 (ref) 13 1.0 (ref) 30 1.0 (ref) 87 1.0 (ref)  
25-29.9 kg/m2 270 0.92 (0.75 – 1.15) 28 1.22 (0.62 – 2.39) 86 1.00 (0.66 – 1.53) 156 0.85 (0.65 – 1.12)  
>30 kg/m2 91 0.88 (0.67 – 1.17) 8 1.14 (0.46 – 2.82) 31 1.04 (0.62 – 1.75) 52 0.78 (0.55 – 1.12)  
            
WC (per 5 cm)   584 0.98 (0.94 - 1.02) 56 0.94 (0.81 – 1.09) 160 1.03 (0.95 – 1.12) 368 0.96 (0.91 – 1.01) 0.29 
WC (per 5 cm) + BMI  1.16 (1.07 – 1.26)  1.12 (0.95 – 1.33)  1.23 (1.10 – 1.37)  1.14 (1.04 – 1.25) 0.31 
          
WHR (per 0.1 unit)   584 1.14 (0.99 – 1.30) 56 0.91 (0.57 – 1.45) 160 1.16 (0.89 – 1.51) 368 1.16 (0.98 – 1.38) 0.63 
WHR (per 0.1 unit) +  BMI  1.42 (1.21 – 1.65)  1.16 (0.72 – 1.88)  1.42 (1.09 – 1.84)  1.45 (1.21 – 1.74) 0.68 
          
HC (per 8 cm) 584 0.84 (0.76 - 0.93) 56 0.85 (0.60 -  1.20) 160 1.01(0.83 -  1.21) 368 0.77 (0.68 -  0.88) 0.077 
          
WC (per 5 cm) + HC   584 1.11 (1.03 – 1.19) 56 1.06 (0.91 – 1.25) 160 1.17 (1.06 – 1.30) 368 1.09 (1.01 – 1.18) 0.29 
HC (per 8 cm) + WC  584 0.69 (0.59 – 0.82) 56 0.83 (0.67 – 1.05) 160 0.83 (0.67 – 1.05) 368 0.64 (0.54 – 0.76) 0.070 
Women           
BMI           
<22.5 kg/m2 68 1.34 (0.94 – 1.93) 15 1.08 (0.53 – 2.21) 11 0.88 (0.40 – 1.93) 42 1.78 (1.06 – 2.97) 0.35 
22.5-24.9 kg/m2 55 1.0 (ref) 16 1.0 (ref) 15 1.0 (ref) 24 1.0 (ref)  
25-29.9 kg/m2 89 1.26 (0.89 – 1.78) 31 1.25 (0.68 – 2.30) 22 1.02 (0.52 – 1.99) 36 1.45 (0.86 – 2.45)  
>30 kg/m2 41 1.37 (0.90 – 2.10) 23 1.91 (0.98 – 3.72)  8 0.99 (0.41 – 2.38) 10 1.03 (0.48 – 2.20)  
          
WC (per 5 cm)   253 1.08 (1.02 – 1.15) 85 1.12 (1.01 –1.23) 56 1.04 (0.91 – 1.18) 112 1.08 (0.99 – 1.18) 0.66 
WC (per 5 cm) + BMI  1.31 (1.18 – 1.46)  1.36 (1.19 – 1.56)  1.25 (1.06 – 1.47)  1.30 (1.15 – 1.48) 0.61 
          
WHR (per 0.1 unit)   253 1.64 (1.38 – 1.93) 85 1.21 (0.87 – 1.69) 56 1.13 (0.73 – 1.73) 112 2.09 (1.70 – 2.56) 0.004 
WHR (per 0.1 unit) + BMI  1.75 (1.47 – 2.08)   1.31 (0.93 – 1.83)   1.22 (0.79 – 1.90)  2.19 (1.78 – 2.70) 0.006 
          
HC (per 8 cm) 253 0.94 (0.83 - 1.06) 85 1.21 (1.01 - 1.46) 56 1.03 (0.80 -  1.33) 112 0.68 (0.55 - 0.84) 0.002 
          
WC (per 5 cm) + HC  253 1.29 (1.18 – 1.41) 85 1.34 (1.19 – 1.52) 56 1.24 (1.07 – 1.44) 112 1.28 (1.15 – 1.43) 0.63 
HC (per 8 cm) + WC 253 0.64 (0.53 – 0.76) 85 0.70 (0.53 – 0.93) 56 0.70 (0.53 – 0.93) 112 0.48 (0.39 – 0.60) 0.0002 
28 
 
a Cox regression models stratified by age, sex, centre and smoking status, adjusted for education and alcohol intake 
b Cox regression models stratified by age, sex, centre, adjusted for education and alcohol intake 
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Table 3:  Measures of adiposity and the risk of HNC among EPIC participants, by HNC site  a  
  Oral cancer  Oropharyngeal 
cancer 
 Hypopharynx  Larynx P heterogeneity 
HNC site 
 
 
n 
cases 
HR (95% CI) b n 
cases 
HR (95% CI) b n 
cases 
HR (95% CI) b n 
cases 
HR (95% CI) b  
Men          
BMI           
<22.5 kg/m2 20 1.96 (1.06 – 3.60) 23 1.70 (1.00 – 2.91) 6 0.68 (0.26 - 1.77) 37 1.68 (1.10 - 2.57) 0.56 
22.5-24.9 kg/m2 21 1.0 (ref) 31 1.0 (ref) 17 1.0 (ref) 55 1.0 (ref)  
25-29.9 kg/m2 54 1.15 (0.66 – 1.95) 68 1.09 (0.70 – 1.68) 23 0.61 (0.33 - 1.15) 115 0.87 (0.63 - 1.21)  
>30 kg/m2 19 1.12 (0.58 – 2.13) 14 0.69 (0.36 – 1.30) 8 0.68 (0.28 - 1.67) 45 0.91 (0.60 - 1.36)  
            
WC (per 5 cm)   114 1.00 (0.91 - 1.10) 136 0.94 (0.86 – 1.03) 54 1.03 (0.88 - 1.20) 252 0.98 (0.92 - 1.05) 0.72 
WC (per 5 cm) + BMI 114 1.21 (1.07 – 1.36) 136 1.13 (1.00 – 1.27) 54 1.24 (1.03 - 1.49) 252 1.18 (1.06 - 1.30) 0.73 
          
WHR (per 0.1 unit)   114 1.26 (0.96 – 1.65) 136 1.00 (0.76 – 1.31) 54 1.42 (0.86 - 2.35) 252 1.12 (0.91 - 1.37) 0.56 
WHR (per 0.1 unit) + BMI 114 1.60 (1.23 – 2.07) 136 1.28 (0.95 – 1.72) 54 1.79  (1.07 - 2.99) 252 1.39 (1.14- 1.68) 0.53 
          
HC (per 8 cm) 114 0.87 (0.68 - 1.11) 136 0.82 (0.65 - 1.02) 54 0.83 (0.57 - 1.20) 252 0.85 (0.74 - 0.98) 0.98 
           
WC (per 5 cm) + HC 114 1.14 (1.02 – 1.27) 136 1.07 (0.97 – 1.18) 54 1.16 (0.98 - 1.37) 252 1.11 (1.02 - 1.21) 0.73 
HC (per 8 cm) + WC 114 0.72 (0.55 – 0.94) 136 0.67 (0.52 – 0.87) 54 0.68 (0.46 - 1.01) 252 0.70 (0.59 - 0.84) 0.98 
 
Women 
         
BMI           
<22.5 kg/m2 23 1.05 (0.60 – 1.84) 20 1.56 (0.74 – 3.25) 3 3.09 (0.33 - 28.87) 14 1.27 (0.56 - 2.85) 0.10 c 
22.5-24.9 kg/m2 26 1.0 (ref) 12 1.0 (ref) 1 1.0 (ref) 13 1.0 (ref)  
25-29.9 kg/m2 27 0.75 (0.43 – 1.30) 30 2.09 (1.08 – 4.02) 5 5.73 (0.59 - 55.66) 18 1.15 (0.57 - 2.32)  
>30 kg/m2 23 1.42 (0.79 – 2.54) 11 2.03 (0.88 – 4.65) 0 n/a 4 0.60 (0.20 - 1.85)  
          
WC (per 5 cm)   99 1.13 (1.02 – 1.24) 73 1.14 (1.04 – 1.24) 9 1.01 (0.77 - 1.34) 49 1.04 (0.94 - 1.16) 0.56 
WC (per 5 cm) + BMI 99 1.40 (1.22 – 1.61)  1.42 (1.25 – 1.61) 9 1.25 (0.92 - 1.72) 49 1.30 (1.11 - 1.51) 0.57 
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WHR (per 0.1 unit)   99 1.72 (1.24 – 2.38) 73 1.68 (1.32 – 2.15) 9 2.00 (0.68 - 5.94) 49 1.71 (1.26 - 2.31) 0.99 
WHR (per 0.1 unit) + BMI 99 1.86 (1.33 – 2.59) 73 1.77 (1.40 – 2.23) 9 2.20 (0.73 - 6.61) 49 1.79 (1.35 - 2.37) 0.97 
  
 
 
 
     
HC (per 8 cm) 99 1.06 (0.87 - 1.29) 73 1.04 (0.85 - 1.26) 9 0.66 (0.47 - 0.91) 49 0.79 (0.58 - 1.09) 0.042 
           
WC (per 5 cm) + HC 99 1.35 (1.19 – 1.53) 73 1.35 (1.20 – 1.52) 9 1.21 (0.90 - 1.64) 49 1.24 (1.08 - 1.41) 0.56 
HC (per 8 cm) + WC  99 0.70 (0.55 – 0.89) 73 0.69 (0.55 – 0.87) 9 0.43 (0.31 - 0.61) 49 0.54 (0.41 - 0.71) 0.033 
a HNC site was defined as oro/hypopharynx not otherwise specified among 23 women and 28 men  
b Cox regression models stratified by age, sex, centre and smoking status, adjusted for education and alcohol intake 
c Among women, the test for interaction between BMI classification and tumour site excluded hypopharynx due to the absence of any cases of hypopharyngeal cancer among 
BMI 25 – 29.9  kg/m2 
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Figure Legends: 
 
Figure 1.  Restricted cubic spline analysis of the association between measured BMI and the risk of 
HNC among men (Fig 1a) and women (Fig 1b) in EPIC;  knots at the 5th, 25th, 75th and 95th percentiles 
of BMI, and models adjusted for education, alcohol intake, and smoking.   
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Figure 1.  Restricted cubic spline analysis of the association between measured BMI and the risk of HNC among men (Fig 
1a) and women (Fig 1b) in EPIC;  knots at the 5th, 25th, 75th and 95th percentiles of BMI, and models adjusted for 
education, alcohol intake, and smoking.   
Fig 1a. 
Fig 1b. 
Supplementary Fig 1b 
Supplementary Fig 1a 
Supplementary Figure 1: Scatterplots of the associations 
between BMI (kg/m2) and WC (Fig 1a) and between BMI 
(kg/m2) and WHR (Fig 1b).  
Supplementary Table 1: Measures of adiposity and the risk of HNC among EPIC participants, including adjustment for weight change after 
baseline 
 Men  Women 
 n cases  Model 1 a Model 2 b  n cases  Model 1 a Model 2 b 
Baseline BMI         
<22.5 kg/m2 51 1.59 (1.10 – 2.29) 1.64 (1.13 – 2.37)  38 1.17 (0.73 – 1.86) 1.18 (0.74 – 1.88) 
22.5-24.9 kg/m2 69 1.0 (reference) 1.0 (reference)  37 1.0 (reference) 1.0 (reference) 
25-29.9 kg/m2 174 1.11 (0.84 – 1.48) 1.07 (0.80 – 1.42)  51 1.13 (0.74 – 1.75) 1.11 (0.72 – 1.71) 
>30 kg/m2 54 1.01 (0.70 – 1.48) 0.90 (0.62 – 1.32)  22 1.14 (0.66 – 2.00) 1.05 (0.60 – 1.86) 
        
Smoking status        
 Never 
      Baseline BMI 
       
<22.5 kg/m2 4 0.88 (0.26 – 2.91) 0.90 (0.27 – 3.00)  9 0.80 (0.33 – 1.89) 0.80 (0.33 – 1.89) 
22.5-24.9 kg/m2 9 1.0 (reference) 1.0 (reference)  13 1.0 (reference) 1.0 (reference) 
25-29.9 kg/m2 19 1.31 (0.58 – 2.97) 1.24 (0.55 – 2.81)  19 0.96 (0.47 – 1.98) 0.95 (0.46 – 1.96) 
>30 kg/m2 7 1.60 (0.57 – 4.50) 1.36 (0.48 – 3.90)  13 1.34 (0.59 – 3.03) 1.25 (0.54 – 2.89) 
Former 
      Baseline BMI 
       
<22.5 kg/m2 9 2.05 (0.88 – 4.78) 2.11 (0.91 – 4.93)  4 0.50 (0.15 – 1.64) 0.51 (0.16 – 1.66) 
22.5-24.9 kg/m2 14 1.0 (reference) 1.0 (reference)  10 1.0 (reference) 1.0 (reference) 
25-29.9 kg/m2 57 1.54 (0.85 – 2.79) 1.48 (0.82 – 2.68)  16 1.35 (0.60 – 3.03) 1.31 (0.58 – 2.95) 
>30 kg/m2 16 1.44 (0.69 – 3.02) 1.31 (0.62 – 2.78)  4 0.90 (0.28 – 2.96) 0.79 (0.24 – 2.59) 
Current 
     Baseline BMI 
       
<22.5 kg/m2 38 1.56 (1.01 – 2.43) 1.62 (1.04 – 2.52)  25 2.01 (1.01 – 3.99) 2.06 (1.04 – 4.10) 
22.5-24.9 kg/m2 46 1.0 (reference) 1.0 (reference)  14 1.0 (reference) 1.0 (reference) 
25-29.9 kg/m2 98 0.94 (0.65 – 1.35) 0.90 (0.63 – 1.30)  16 1.21 (0.58 – 2.54) 1.18 (0.57 – 2.48) 
>30 kg/m2 
 
31 0.82 (0.50 – 1.33) 0.72 (0.44 – 1.19)  5 0.90 (0.31 – 2.68) 0.81 (0.27 – 2.45) 
Interaction by smoking status:  0.60 0.55   0.21 0.21 
a Cox regression models stratified by age, sex, centre and smoking status, adjusted for education and alcohol intake 
 b Same covariates as model 1, further adjusted for self-reported difference in weight over time (kg/year) 
 
Supplementary Table 2: Measures of adiposity and the risk of HNC among EPIC participants, by 
smoking status at baseline and second questionnaire  
  Never smokers,  
baseline and second a 
questionnaire 
 Current smokers, 
baseline and second a 
questionnaire 
 n cases HR (95% CI) n cases HR (95% CI) 
Men     
Baseline BMI      
<22.5 kg/m2 5 1.69 (0.53 – 5.42) 30  1.51 (0.93 – 2.45) 
22.5-24.9 kg/m2 7 1.0 (ref) 40 1.0 (ref) 
25-29.9 kg/m2 20 1.74 (0.73 – 4.18) 80 0.89 (0.60 – 1.32) 
>30 kg/m2 7 2.23 (0.76 – 6.57) 24 0.70 (0.40 – 1.20) 
       
WC (per 5 cm)   39 1.13 (0.96 – 1.33) 174 0.97 (0.89 – 1.05) 
       
WHR (per 0.1 unit)   39 1.22 (0.69 – 2.15) 174 1.14 (0.88 – 1.48) 
     
HC (per 8 cm) 39 1.32 (0.91 - 1.90) 174 0.80 (0.67 - 0.97) 
     
WC (per 5 cm) + HC 39 1.26 (1.04 – 1.53) 174 1.08 (0.96 – 1.23) 
HC (per 8 cm) + WC 39 1.09 (0.71 – 1.67) 174 0.67 (0.51 – 0.88) 
       
Women     
Baseline BMI     
<22.5 kg/m2 10  1.22 (0.50 – 2.98) 21 1.91 (0.90 – 4.09) 
22.5-24.9 kg/m2 10 1.0 (ref) 11 1.0 (ref) 
25-29.9 kg/m2 21 1.32 (0.61 – 2.86) 16 1.38 (0.62 – 3.05) 
>30 kg/m2 15 1.94 (0.83 – 4.51) 6 1.45 (0.50 -4 .21) 
     
WC (per 5 cm)   56 1.11 (0.98 – 1.26) 54 1.06 (0.93 – 1.20) 
     
WHR (per 0.1 unit)   56 1.14 (0.74 – 1.76) 54 1.91 (1.37 – 2.66) 
     
HC (per 8 cm) 56 1.23 (0.98 - 1.56) 54 0.73 (0.54 - 0.98) 
     
WC (per 5 cm) + HC 56 1.28 (1.08 – 1.51) 54 1.21 (1.03 – 1.43) 
HC (per 8 cm) + WC 56 0.88 (0.65 – 1.21) 54 0.52 (0.37 – 0.74) 
a  Second questionnaire completed on average 5 years after baseline 
b Cox regression models stratified by age and centre; adjusted for education and alcohol intake 
 
Supplementary Table 3:  Measures of adiposity and the risk of HNC in the EPIC study, excluding Oxford participants with calibrated self-reported 
anthropometry  
  All participants  Never  Former  Current  
Men 
n 
cases HR (95% CI) a 
n 
cases HR (95% CI) b 
n 
cases HR (95% CI) b 
n 
cases HR (95% CI) b 
p for 
interaction 
by smoking 
status 
        
BMI   
<22.5 kg/m2 90 1.68 (1.27 – 2.21) 6 1.45 (0.53 – 4.00) 13 1.58 (0.81 – 3.07) 71 1.68 (1.22 – 2.32) 0.88 
22.5-24.9 kg/m2 125 1.0 (ref) 11 1.0 (ref) 28 1.0 (ref) 86 1.0 (ref)  
25-29.9 kg/m2 264 0.93 (0.75 – 1.15) 24 1.16 (0.56 – 2.41) 84 1.06 (0.69 – 1.64) 156 0.86 (0.65 – 1.13)  
>30 kg/m2 91 0.90 (0.68 – 1.19) 8 1.22 (0.47 – 3.14) 31 1.15 (0.68 – 1.96) 52 0.78 (0.54 – 1.12)  
            
WC (per 5 cm)   570 0.98 (0.94 – 1.02) 49 0.95 (0.81 – 1.10) 156 1.05 (0.97-1.14) 365 0.96 (0.91 – 1.01) 0.30 
+ adjusted for BMI  1.18 (1.08 – 1.28)  0.77 (0.58 – 1.03)  1.21 (1.03 – 1.42)  1.23 (1.11 – 1.37)  
          
WHR (per 0.1 unit)   570 1.15 (0.99 – 1.32) 49 0.95 (0.58 – 1.56) 156 1.22 (0.94 – 1.60) 365 1.15 (0.97 – 1.37) 0.67 
+ adjusted for BMI  1.43 (1.23 – 1.67)  0.89 (0.49 – 1.60)  1.32 (0.98 – 1.78)  1.58 (1.31 – 1.90)  
          
Women          
BMI           
<22.5 kg/m2 58 1.58 (1.06 – 2.36) 11 1.34 (0.58 – 3.12) 9 0.82 (0.35 – 1.93) 38 2.29 (1.30 – 4.04) 0.20 
22.5-24.9 kg/m2 44 1.0 (ref) 11 1.0 (ref) 14 1.0 (ref) 19 1.0 (ref)  
25-29.9 kg/m2 82 1.38 (0.95 – 2.01) 30 1.56 (0.78 – 3.15) 18 0.86 (0.42 – 1.77) 34 1.74 (0.99 – 3.08)  
>30 kg/m2 39 1.50 (0.96 – 2.35) 22 2.25 (1.06 -4.77) 7 0.83 (0.33 – 2.12) 10 1.28 (0.58 – 2.83)  
          
WC (per 5 cm)   223 1.08 (1.02 – 1.15) 74 1.12 (1.01 – 1.25) 48 1.01 (0.87 – 1.16) 101 1.09 (0.99 – 1.19) 0.39 
+ adjusted for BMI  1.37 (1.22 – 1.54)  1.17 (0.96 – 1.43)  1.07 (0.82 – 1.39)  1.78 (1.50 – 2.11)  
          
WHR (per 0.1 unit)   223 1.64 (1.38 – 1.95) 74 1.26 (0.89 – 1.79) 48 1.02 (0.64 – 1.63) 101 2.09 (1.69 – 2.60) 0.003 
+ adjusted for BMI  1.78 (1.49 – 2.12)  1.15 (0.79 – 1.70)  1.06 (0.64 – 1.77)  2.51 (2.00 – 3.15)  
a Cox regression models stratified by age, sex, centre and smoking status, adjusted for education and alcohol intake 
b Cox regression models stratified by age, sex, centre, adjusted for education and alcohol intake 
 
